… one or more antidepressant(s) Discontinuation-emergent cataplexy FDA is evaluating … Oral Suspension (mycophenolate mofetil)  Myfortic (mycophenolic acid) delayed-release … information about hepatotoxicity.  An FDA Drug Safety Communication was issued on …

… the approximate invoice price pharmacies pay for medications in the United States … included 51 specialty generic drugs comprising 882 National Drug Codes. These include … to treat renal disease and Myfortic, which is used by transplant …

… how PBMs handle specialty generic drugs. PBM-affiliated pharmacies dispensed a disproportionate share of … specialty generic drugs, including critical medications such as Ampyra, Gleevec, Sensipar, and Myfortic. These drugs accounted …

… specialty generic drugs at affiliated pharmacies, steering more profitable specialty drugs toward those … a wide range of lifesaving drugs, including medications to treat heart disease … an inhaled medication for cystic fibrosis marked up 339%, and Myfortic, an …

… a wide range of lifesaving drugs, including medications to treat heart disease … to treat renal disease), and Myfortic (used by transplant recipients).  The … numerous specialty generic drugs dispensed at their affiliated pharmacies—including drugs used to …

… that conduct clinical trials at 300 sites … drugmaker may prefer a sale to a pharmaceutical company. For the current fiscal, Novartis … , Sandimmun, Neoral and Myfortic, administered to patients who … primarily contributed by increased medical tourism supported by …

… set to go to trial last year before … pharmacies in order to increase sales of its Exjade and Myfortic drugs … Some doctors who wrote thousands of prescriptions for Novartis drugs raked … doctors to choose the best treatment for their patients and increases drug …

Pharma major Lupin on Thursday said its alliance partner Concord Biotech has received … the United States Food and Drug Administration (USFDA) is to market … a generic version of Novartis Pharmaceuticals Corporation's Myfortic delayed-release tablets …

… kickbacks to doctors in return for prescribing its medicines. The … Novartis paid $422m to settle allegations that it marketed the epilepsy drug … kickbacks involving specialty pharmacy prescribing of Myfortic and thalassaemia treatment Exjade (deferasirox), …

… 39;s offering. Myfortic Drug Insight, 2019 highlights the drug marketed details and … 47;research/p558mr/myfortic—drug?w=4 View source version … and Kidney Disorders Drugs KEYWORD: INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL SOURCE: Research …